US 12234480
Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
granted A61KA61K2035/122A61K2035/124
Quick answer
US patent 12234480 (Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells) held by Regents of the University of Minnesota expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2035/122, A61K2035/124, A61K2039/515, A61K2039/545